Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 5/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.60 |
| ▸ | SIRT6 | Q8N6T7 | 2/20 | 0.60 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.60 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.60 |
| ▸ | PGR | P06401 | 1/20 | 0.60 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.60 |
| ▸ | RXRA | P19793 | 1/20 | 0.60 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.60 |
| ▸ | CCKAR | P32238 | 1/20 | 0.60 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.60 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.60 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.60 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.60 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9043559 | 0.89 | HMGCR (0.61) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL9043573 | 0.89 | HMGCR (0.61) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL19231539 | 0.87 | CYP2C9 (0.55) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL12073720 | 0.86 | CYP2C9 (0.60) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL12192328 | 0.85 | CYP2C9 (0.65) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL1876635 | 0.82 | CYP2C9 (0.57) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL5847130 | 0.82 | CYP2C9 (0.60) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL29999171 | 0.82 | CYP2C9 (0.60) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL5847132 | 0.82 | CYP2C9 (0.60) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL13292039 | 0.82 | CYP2C9 (0.57) | HMGCRCYP2C9SIRT6ABCC3ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230026095-A1 | PROCESS FOR THE CONTINUOUS MANUFACTURE OF STATINS | Dr Reddys Laboratories Ltd (IN) | 2023-01-26 | — | — | US | disclosed |
| US-20100145046-A1 | Substituted 3-hydroxy-delta-lactones from epoxides | ENERGY, UNITED STATES DEPARTMENT OF | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230026095-A1 | PROCESS FOR THE CONTINUOUS MANUFACTURE OF STATINS | HMGCR, PCSK9, CETP | HMGCR 1/4885CYP2C9 173/4885SIRT6 1728/4885 |
| US-20100145046-A1 | Substituted 3-hydroxy-delta-lactones from epoxides | EBP, CYP8B1, HSD3B2 | HMGCR 160/4885CYP2C9 153/4885SIRT6 3907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.